XML 38 R31.htm IDEA: XBRL DOCUMENT v2.4.0.8
Stock-Based Compensation (Tables)
6 Months Ended
Jan. 31, 2014
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Summary of Stock-based Awards Outstanding by Award Type
As of January 31, 2014, the following stock-based awards, by award type, were outstanding:

 
January 31, 2014
Stock options
2,737,445

Performance shares
117,210

RSUs and restricted stock
37,326

Share units
6,874

SARs
7,000

Total
2,905,855

Stock-based compensation for awards detailing where recorded in Condensed Consolidated Statement of Operations
Stock-based compensation for awards issued is reflected in the following line items in our Condensed Consolidated Statements of Operations:
 
 
Three months ended January 31,
 
Six months ended January 31,
 
 
2014
 
2013
 
2014
 
2013
Cost of sales
 
$
84,000

 
74,000

 
137,000

 
119,000

Selling, general and administrative expenses
 
832,000

 
614,000

 
1,603,000

 
1,215,000

Research and development expenses
 
153,000

 
118,000

 
276,000

 
217,000

Stock-based compensation expense before income tax benefit
 
1,069,000

 
806,000

 
2,016,000

 
1,551,000

Estimated income tax benefit
 
(403,000
)
 
(346,000
)
 
(749,000
)
 
(610,000
)
Net stock-based compensation expense
 
$
666,000

 
460,000

 
1,267,000

 
941,000

Summary of net stock-based compensation expense by award type
Stock-based compensation expense, by award type, is summarized as follows:

 
 
Three months ended January 31,
 
Six months ended January 31,
 
 
2014
 
2013
 
2014
 
2013
Stock options
 
$
719,000

 
638,000

 
1,367,000

 
1,211,000

Performance shares
 
230,000

 
86,000

 
407,000

 
172,000

ESPP
 
43,000

 
48,000

 
88,000

 
101,000

RSUs and restricted stock
 
68,000

 
28,000

 
136,000

 
60,000

Share units
 
6,000

 
6,000

 
12,000

 
12,000

Equity-classified stock-based compensation expense
 
1,066,000

 
806,000

 
2,010,000

 
1,556,000

Liability-classified stock-based compensation expense (benefit) (SARs)
 
3,000

 

 
6,000

 
(5,000
)
Stock-based compensation expense before income tax benefit
 
1,069,000

 
806,000

 
2,016,000

 
1,551,000

Estimated income tax benefit
 
(403,000
)
 
(346,000
)
 
(749,000
)
 
(610,000
)
Net stock-based compensation expense
 
$
666,000

 
460,000

 
1,267,000

 
941,000

Components of actual Income tax benefit recognized for tax deductions relating to settlement of stock-based awards
The following table provides the components of the actual income tax benefit recognized for tax deductions relating to the settlement of stock-based awards:

 
 
Six months ended January 31,
 
 
2014
 
2013
Actual income tax benefit recorded for the tax deductions relating to the settlement of stock-based awards
 
$
174,000

 
79,000

Less: Tax benefit initially recognized on settled stock-based awards vesting subsequent to the adoption of accounting standards that require us to expense stock-based awards, excluding income tax shortfalls
 
145,000

 
60,000

Excess income tax benefit recorded as an increase to additional paid-in capital
 
29,000

 
19,000

Less: Tax benefit initially disclosed but not previously recognized on settled equity-classified stock-based awards vesting prior to the adoption of accounting standards that require us to expense stock-based awards, excluding income tax shortfalls
 
13,000

 

Excess income tax benefit from settled equity-classified stock-based awards reported as a cash flow from financing activities in our Condensed Consolidated Statements of Cash Flows
 
$
16,000

 
19,000

Summary of the Plan's activity relating to stock options (including SARs)
The following table summarizes the Plan's activity (including SARs) during the six months ended January 31, 2014:

 
 
Awards
(in Shares)
 
Weighted Average
Exercise Price
 
Weighted Average
Remaining Contractual
Term (Years)
 
Aggregate
Intrinsic Value
Outstanding at July 31, 2013
 
3,047,910

 
$
29.94

 
 
 
 
Granted
 
247,000

 
27.23

 
 
 
 
Expired/canceled
 
(413,240
)
 
45.66

 
 
 
 
Exercised
 
(4,050
)
 
19.54

 
 
 
 
Outstanding at October 31, 2013
 
2,877,620

 
27.46

 
 
 
 
Granted
 
11,000

 
31.29

 
 
 
 
Expired/canceled
 
(52,800
)
 
27.80

 
 
 
 
Exercised
 
(91,375
)
 
27.14

 
 
 
 
Outstanding at January 31, 2014
 
2,744,445

 
$
27.48

 
5.47
 
$
8,134,000

 
 
 
 
 
 
 
 
 
Exercisable at January 31, 2014
 
1,408,803

 
$
27.18

 
3.00
 
$
4,612,000

 
 
 
 
 
 
 
 
 
Vested and expected to vest at January 31, 2014
 
2,678,766

 
$
27.47

 
5.42
 
$
7,971,000

Certain weighted average assumptions used to estimate the fair value of stock-based awards
 
 
Three months ended January 31,
 
Six months ended January 31,
 
 
2014
 
2013
 
2014
 
2013
Expected dividend yield
 
3.84
%
 
4.29
%
 
4.03
%
 
4.29
%
Expected volatility
 
32.00
%
 
37.00
%
 
32.85
%
 
37.00
%
Risk-free interest rate
 
1.50
%
 
0.61
%
 
1.39
%
 
0.61
%
Expected life (years)
 
5.31

 
5.31

 
5.44

 
5.31


Summary of the Plan's activity relating to performance shares, RSUs, restricted stock and share units
The following table summarizes the Plan's activity relating to performance shares, RSUs, restricted stock and share units:
 
 
Awards
(in Shares)
 
Weighted Average
Grant Date
Fair Value
 
Aggregate
Intrinsic Value
Outstanding at July 31, 2013
 
102,334

 
$
25.80

 
 
Granted
 
68,167

 
24.58

 
 
Converted to common stock
 
(4,509
)
 
26.25

 
 
Outstanding at October 31, 2013
 
165,992

 
25.28

 
 
Granted
 
4,988

 
31.32

 
 
Converted to common stock
 

 

 
 
Forfeited
 
(9,570
)
 
24.82

 
 
Outstanding at January 31, 2014
 
161,410

 
$
25.50

 
$
4,910,000

 
 
 
 
 
 
 
Vested at January 31, 2014
 
12,529

 
$
26.93

 
$
381,000

 
 
 
 
 
 
 
Vested and expected to vest at January 31, 2014
 
156,337

 
$
25.51

 
$
4,756,000